"Amabwiriza yo gutera inshinge zidafite inshinge ku barwayi ba diyabete" yasohotse mu Bushinwa, aho hagaragajwe ko hashyizweho ku mugaragaro inshinge za insuline zidafite inshinge mu mavuriro ya diyabete yo mu Bushinwa, ndetse inagira Ubushinwa mu gihugu ku mugaragaro mu rwego rwo guteza imbere urushinge. tekinoroji yubuvuzi.
Muri icyo gihe kandi, mu gihugu hose hatangijwe gahunda yo gutera inshinge zidafite inshinge za insuline, kandi inshinge zitagira inshinge zakoreshejwe mu cyumba cy’ibitaro amagana byo mu Bushinwa, biba igikoresho cya mbere cyo gutera inshinge zidafite inshinge zemewe nk'igikoresho cyo kuvura.
Nkumushinga wambere mubijyanye no gutera inshinge zidafite inshinge mubushinwa, guhanga udushya mu ikoranabuhanga ryindege "TECHiJET" byabonye igishushanyo mbonera cyerekana imiterere ya "TECHiJET" yerekana imashini itangiza inshinge zidafite inshinge zitandukanye, hamwe no kugenzura neza y'ubujyakuzimu bwimbitse hamwe n'ahantu ho gukwirakwizwa., gufatanya nibiyobyabwenge kugirango ugere kubikorwa byiza.Kubwibyo, TECHiJETneedle idafite siringe ntabwo ari igikoresho cyoroshye cyo kumenyekanisha gusa, ahubwo ni gahunda yo kuvura ibiyobyabwenge.
Mbere yo gukoreshwa ku ivuriro, "TECHiJET" yakoze umubare munini w’ubuvuzi bw’amatwi.
"Imiti ya Pharmacokinet na Pharmacodyna mics Kwiga Humalog nta inshinge zatewe inshinge" yakozwe na Profeseri cyangwa Li Qifu wo mu bitaro bya mbere bishamikiye kuri H ospital ya kaminuza y’ubuvuzi ya Chongqing mu 2015 yemeza med ko ugereranije n’urushinge-rufunguzo rwa yringe rwa "TECHiJET" rutagira urushinge syringe, kwinjiza insuline Byihuse kandi byegereye uburyo bwo gusohora umubiri wa insuline;
Mu mwaka wa 2016, ubushakashatsi "Kugereranya ingaruka s inshinge -fr ee inshinge ion hamwe n'ikaramu gakondo ya insu lin ku kugenzura isukari ya bloo d no kurwego rwa insuline ku barwayi bafite T 2DM" byakozwe na Porofeseri Xiao Xinhua wo mu Ishuri Rikuru ry’Ubuvuzi rya Peking H osp ital na Professor Guo Lix mubitaro bya Beijing bemeza med: "Qu ick Shure" urushinge -inshinge yubusa Ugereranije ninshinge za wit h,
postprandia l kugenzura isukari yamaraso nibyiza, kandi ihindagurika ryisukari yamaraso ni nto;
Guhera mu 2018, yamaze imyaka 2 kandi iyobowe na Profeseri cyangwa Ji Linong wo mu bitaro bya Beijing Peop le maze bafatanya gutangiza ubushakashatsi bwa P hase III hamwe n’ibitaro 10 byo mu rwego rwo hejuru.T we "KUBUNTU" yiga akoresheje urushinge rwa "T ECHiJET" -r ee s yringe kuri ubu ntabwo arinini kwisi.Ubushakashatsi bwaduteye kumenya igipimo cya zahabu cyo kugenzura amaraso "gar glycat ed hemoglobin" nkigipimo nyamukuru cyerekana ko abantu benshi bayobowe na C hina, itsinda ry’inzobere mu bya endocrinology, ryemeje ibyiza bya "TECHiJET" ridafite urushinge ikoranabuhanga ryumva kandi ritezimbere ubushobozi bwo guhanga udushya, ariko kandi ryerekana Ubushinwa nta guhanga udushya no gukoresha amavuriro agaciro ka e kwa clinique l res earch ku inshinge inshinge ion t echnology.T we "KUBUNTU" ubushakashatsi bwemeza med imyanzuro ikurikira:
Ugereranije wit h insuline wit h urushinge, impinduka fr om baseline muri HbA1c idafite inshinge ntabwo yari ior ior mumatsinda ya insuline p en group, kandi yari ifite statistique isumba y na clinique sup eriority; inshinge-fr ee insuline, natwe turi bake dos es ya insuline kuruta inshinge zamakaramu ya insuline; Nta inshinge zatewe inshinge za insu lin, ikibazo cya ion reaction reaction kuri site yatewe inshinge ni nke, kandi nta induration ibaho; Urushinge-fr ee inshinge ion ya insu lin itera ububabare buke kandi hejuru kunyurwa n’abarwayi, ibyo bikaba bishobora gutuma abarwayi bubahirizwa. "TECHiJET" izakomeza e kuba ikoranabuhanga rya mbere ku isi - tekinoroji yo gutera inshinge nk’ibanze mu kugirira akamaro abarwayi no kwivuza mu mutekano.Ni r espons ibility a nd ideal ya "T ECHiJET" kugirango iteze imbere iterambere ryubumenyi n’ikoranabuhanga mu bukungu bw’ubuvuzi bw’igihugu, kandi icyerekezo cyo "kwisuzumisha nta nshinge ni no kuvura imitekerereze, bigatuma isi iba ahantu heza" ubushake rwose kugerwaho vuba bishoboka.
Igihe cyo kohereza: Ukwakira-13-2022